Cargando…

DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score

PURPOSE: In prostate cancer, the indication to irradiate the pelvic lymphatic pathways in clinical node-negative patients is solely based on clinical nomograms. To define biological risk patterns of lymphatic spread, we studied DNA-methylation and genomic copy number in primary tumors and correspond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unger, Kristian, Hess, Julia, Link, Vera, Buchner, Alexander, Eze, Chukwuka, Li, Minglun, Stief, Christian, Kirchner, Thomas, Klauschen, Frederick, Zitzelsberger, Horst, Niyazi, Maximilian, Ganswindt, Ute, Schmidt-Hegemann, Nina-Sophie, Belka, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Special Issue on Personalized Radiation Oncology; Edited by Daniel Zips, Pierre Blanchard
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014335/ https://www.ncbi.nlm.nih.gov/pubmed/36935856 http://dx.doi.org/10.1016/j.ctro.2023.100586

Ejemplares similares

Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) – A phase I trial
por: Waqar, Mueez, et al.
Publicado: (2023)

A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study
por: Nicosia, Luca, et al.
Publicado: (2022)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
por: Hoegen, Philipp, et al.
Publicado: (2022)

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
por: Tran, Kevin T., et al.
Publicado: (2023)

Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer
por: Gjyshi, Olsi, et al.
Publicado: (2023)

Artificial intelligence to predict outcomes of head and neck radiotherapy
por: Bang, Chulmin, et al.
Publicado: (2023)

Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT)
por: Wu, Trudy C., et al.
Publicado: (2023)

GI factors, potential to predict prostate motion during radiotherapy; a scoping review
por: Alexander, S.E., et al.
Publicado: (2023)

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
por: Oetting, Agnes, et al.
Publicado: (2023)

Novel unconventional radiotherapy techniques: Current status and future perspectives – Report from the 2nd international radiation oncology online seminar
por: Tubin, S., et al.
Publicado: (2023)

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2017)

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2018)

PSMA-positive nodal recurrence in prostate cancer: Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Investigating a Correlation between Chemoradiotherapy Schedule Parameters and Overall Survival in a real-life LD SCLC Patient Cohort
por: Manapov, Farkhad, et al.
Publicado: (2016)

Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial Design
por: Kretschmer, Alexander, et al.
Publicado: (2021)

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
por: Rogowski, Paul, et al.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment
por: Hegemann, Nina-Sophie, et al.
Publicado: (2016)

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2021)

Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis
por: Schmidt Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
por: Rogowski, Paul, et al.
Publicado: (2021)

Intra-fraction motion of the prostate is not increased by patient couch shifts
por: Ballhausen, Hendrik, et al.
Publicado: (2016)

The treatment of aneurysmal bone cysts
por: van Geloven, Thomas P.G., et al.
Publicado: (2023)

Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
por: Shi, Run, et al.
Publicado: (2020)

Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy
por: Manapov, Farkhad, et al.
Publicado: (2016)

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
por: Niyazi, Maximilian, et al.
Publicado: (2016)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
por: Niyazi, Maximilian, et al.
Publicado: (2010)

A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT
por: Li, Minglun, et al.
Publicado: (2015)

Radiotherapy of oligometastatic prostate cancer: a systematic review
por: Rogowski, Paul, et al.
Publicado: (2021)

A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
por: Shi, Run, et al.
Publicado: (2019)

Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort
por: Niyazi, Maximilian, et al.
Publicado: (2014)

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
por: Niyazi, Maximilian, et al.
Publicado: (2014)

A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC)
por: Wintergerst, Ludmila, et al.
Publicado: (2018)

Moderate hypofractionated image-guided thoracic radiotherapy for locally advanced node-positive non-small cell lung cancer patients with very limited lung function: a case report
por: Manapov, Farkhad, et al.
Publicado: (2017)

Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis
por: Hegemann, Nina-Sophie, et al.
Publicado: (2017)

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
por: Manapov, Farkhad, et al.
Publicado: (2018)

Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Schüttrumpf, Lars, et al.
Publicado: (2020)

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy
por: Li, Minglun, et al.
Publicado: (2022)

Novel modified patient immobilisation device with an integrated coil support system for MR-guided online adaptive radiotherapy in the management of brain and head-and-neck tumours
por: Konnerth, Dinah, et al.
Publicado: (2021)

MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients
por: Eze, Chukwuka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5g75bv2meesarjf5bak4lvirv